|
|
Post by mnholdem on Jul 30, 2019 20:16:52 GMT -5
Billboards and radio? That’s focused advertising designed to draw area patients to their clinic. It’s probably more effective and definitely much more cost-effective than regional TV campaigns.
I was also interested in VDex’s approach of soliciting referrals from local endocrinologists. “Send a few of your toughest patients and how our diabetes treatment works for them.” Working with Endos and not against them. Pretty smart, even considering some Endos might see them as a threat to their business. It’s a disarming tactic to be sure.
Steve estimates that VDex has a marketing spend of ~$200 per patient and an excellent retention rates after they begin treatment. That’s amazing.
I’m looking forward to seeing new VDex clinics. Many new clinics.
I’m also looking forward to MannKind’s new sales strategy gaining some traction.
|
|
|
|
Post by rtmd on Jul 30, 2019 20:20:49 GMT -5
You are way off base, they don’t advertise on their Facebook Page. They advertise in the local areas where they have clinics. ( DTC ) 5 mile radius. ( On FB) They go to JDRF events. Pediatric camps have been something that they have been asked to attend and speak at. I would love to see some hard numbers. I like the exposure they are getting; any invitation is a good invitation. But what about script numbers, patient numbers, profitability? That post this afternoon was lacking in details that show what each VDEX clinic can achieve. Where’s the beef?! 🙃 The post said they advertise on social media. Can you provide a link to one of these ads? I see nothing in that photo indicating that it has anything to do with VDEX. Can you provide any evidence of their appearance at any event? I would also point out that tweet was from 4 months ago and has all of 3 retweets and 3 likes. |
|
|
|
Post by mnholdem on Jul 30, 2019 20:29:27 GMT -5
|
|
|
|
Post by rtmd on Jul 30, 2019 20:31:55 GMT -5
Billboards and radio? That’s focused advertising designed to draw area patients to their clinic. It’s probably more effective and definitely much more cost-effective than regional TV campaigns. I was also interested in VDex’s approach of soliciting referrals from local endocrinologists. “Send a few of your toughest patients and how our diabetes treatment works for them.” Working with Endos and not against them. Pretty smart, even considering some Endos might see them as a threat to their business. It’s a disarming tactic to be sure. Steve estimates that VDex has a marketing spend of ~$200 per patient and an excellent retention rates after they begin treatment. That’s amazing. I’m looking forward to seeing new VDex clinics. Many new clinics. I’m also looking forward to MannKind’s new sales strategy gaining some traction. How do they get referrals from endos? How do the endos even know they exist? They don't have sales people. They surely don't just call them on the phone and make claims about success. Do they mail out evidence to support their claim to be able to treat the "toughest patients"? Moreover, I seriously doubt any endo is going to admit to being incapable of managing a diabetes patient to the point where he/she requests an outfit like VDEX to intervene. And "Steve" specifically referred to social media ads, not to billboards and radio. Has anyone seen any VDEX ads anywhere? |
|
|
|
Post by mnholdem on Jul 30, 2019 20:39:52 GMT -5
I would think just the people in those areas. I don’t have a VDex near me. I’m curious why you ask. Do you think VDex management would publish something that could be disputed? You seem to be suggesting that they are lying!
|
|
|
|
Post by sportsrancho on Jul 30, 2019 20:41:59 GMT -5
I would think just the people in those areas. I don’t have a VDex near me. Correct you’d have to be in a 5 mile radius of one of the clinics. Since I’m not I have no idea how to provide a screenshot. Not to mention I’m not on Facebook. |
|
|
|
Post by rtmd on Jul 30, 2019 20:50:01 GMT -5
Charles long is an anesthesiologist in Charlotte, NC. Huizenga is a pseudocelebrity doctor who was kicked off TV for using "unsafe and illegal weight-loss methods" on "The Biggest Loser." Paul McCullough -- Bill's dad? -- is an orthopedic surgeon who retired 19 years ago. Peter Waldstein is a Beverly Hills pediatrician. Patrick Moore is a general surgeon in Murietta, CA. Kristen Davis is a surgical physician's assistant. James McCullough -- Bill's brother -- is an anesthesiologist. Courtney Mizuhara-Cheng is an young osteopath practicing general medicine. I don't see a whole lot of experience managing chronic diabetes. VDEX couldn't recruit even one endo? |
|
|
|
Post by goyocafe on Jul 30, 2019 20:53:55 GMT -5
I would love to see some hard numbers. I like the exposure they are getting; any invitation is a good invitation. But what about script numbers, patient numbers, profitability? That post this afternoon was lacking in details that show what each VDEX clinic can achieve. Where’s the beef?! 🙃 why is it you demand to see vdex numbers but don’t care what Mnkd numbers are they spent 50 million last year on promoting Afrezza. What is their profit? It seems we already know numbers from MNKD, don’t we. You just stated them, and between that and weekly scripts, there’s a lot that can be extrapolated. Care to guess how many patients VDEX has treated, scrips written? I haven’t a clue based on any of the information that’s been presented so far. Just asking for some real numbers. |
|
|
|
Post by rtmd on Jul 30, 2019 20:55:59 GMT -5
I would think just the people in those areas. I don’t have a VDex near me. I’m curious why you ask. Do you think VDex management would publish something that could be disputed? You seem to be suggesting that they are lying! The only thing I'm suggesting is that I can't find any evidence of public awareness of VDEX. There are no articles about VDEX. VDEX isn't mentioned in any diabetic forums. There are no news reports about VDEX or VDEX patients Everything about VDEX comes from VDEX. It strikes me as strange that they assert so much success yet no one seems to know they exist -- except Mannkind shareholders, of course. |
|
|
|
Post by lifebreath on Jul 30, 2019 20:56:33 GMT -5
Billboards and radio? That’s focused advertising designed to draw area patients to their clinic. It’s probably more effective and definitely much more cost-effective than regional TV campaigns. I was also interested in VDex’s approach of soliciting referrals from local endocrinologists. “Send a few of your toughest patients and how our diabetes treatment works for them.” Working with Endos and not against them. Pretty smart, even considering some Endos might see them as a threat to their business. It’s a disarming tactic to be sure. Steve estimates that VDex has a marketing spend of ~$200 per patient and an excellent retention rates after they begin treatment. That’s amazing. I’m looking forward to seeing new VDex clinics. Many new clinics. I’m also looking forward to MannKind’s new sales strategy gaining some traction. How do they get referrals from endos? How do the endos even know they exist? They don't have sales people. They surely don't just call them on the phone and make claims about success. Do they mail out evidence to support their claim to be able to treat the "toughest patients"? Moreover, I seriously doubt any endo is going to admit to being incapable of managing a diabetes patient to the point where he/she requests an outfit like VDEX to intervene. And "Steve" specifically referred to social media ads, not to billboards and radio. Has anyone seen any VDEX ads anywhere? The multi- million dollar adverting campaign of Mnkd’s was a complete failure obviously vdex has a superior strategy of promoting Afrezza. How many adds did you see of Afrezza put out by Mnkd? The ultimate success of Afrezza will be through systemic growth. If we can only get Kresa and Castagna out of our way. |
|
|
|
Post by agedhippie on Jul 30, 2019 20:58:24 GMT -5
I think what VDex is saying, and I can see why, is the the FDA want to see a bright line between VDex and Mannkind. That leads me to wonder if the distributor is there to provide that bright line - VDex -> HFM -> MNKD rather than VDex -> MNKD which they have objected to in the past.
|
|
|
|
Post by mnholdem on Jul 30, 2019 21:03:03 GMT -5
Labyrinth Primary Care & Holistic Health Apr 26, 2019 Tired of Needles? Needle-less Diabetes Treatment Is Here! This is the medical center that partnered with VDex in Albuquerque NM. Link: m.facebook.com/hashtag/vdexdiabetes?__tn__=%2As-RGoogle Labyrinth. Or check this out: picdeer.com/labyrinthdpcI’m not versed on how to copy the ad to post here. Maybe one of you can? |
|
|
|
Post by sportsrancho on Jul 30, 2019 21:06:01 GMT -5
|
|
|
|
Post by rtmd on Jul 30, 2019 21:06:20 GMT -5
I would think just the people in those areas. I don’t have a VDex near me. Correct you’d have to be in a 5 mile radius of one of the clinics. Since I’m not I have no idea how to provide a screenshot. Not to mention I’m not on Facebook. Why would they limit advertising to within 5 miles of a clinic? Indeed,how many diabetics can be expected within five miles of a clinic who would actually see a facebook ad about the clinic? And what percent of those might actually respond to such an ad? Overall, a pretty small number I suspect. |
|
|
|
Post by lifebreath on Jul 30, 2019 21:12:25 GMT -5
why is it you demand to see vdex numbers but don’t care what Mnkd numbers are they spent 50 million last year on promoting Afrezza. What is their profit? It seems we already know numbers from MNKD, don’t we. You just stated them, and between that and weekly scripts, there’s a lot that can be extrapolated. Care to guess how many patients VDEX has treated, scrips written? I haven’t a clue based on any of the information that’s been presented so far. Just asking for some real numbers. I don’t know the vdex financials and it is none of my business. I am not a partner or shareholder in Vdex. The success of Vdex is directly related to sales of Afrezza. The vdex investors will only see returns from their investment by sales of Afrezza. That creates a high level of motivation to see their protocol succeed. They are not taking your money. Conversely Kresa and the BOD, Castagna and his management will continue to receive unconscionable salaries rather sales are good bad or nonexistent. Additionally the business plan Bill (vdex) has recently revealed is right in line with how I believed MnKd’s strategy should have been since Afrezza was returned to them. The brilliance of VDEX is following Al Mann’s number one mantra “take care of the Patient.” |
|
